Projects per year
Fingerprint
Dive into the research topics where Robert Patrick Doyle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting the GDF15-GFRAL System to Treat Nausea and Emesis
National Institutes of Health/DHHS, University of Pennsylvania
8/9/21 → 5/31/25
Project: Research project
-
Second Generation GLP-1 Agonists without Nausea/emesis Side Effects
National Institutes of Health/DHHS, University of Pennsylvania
3/1/21 → 2/28/22
Project: Research project
-
Appetite-Suppressing Effects of Novel Glucoregulatory Chimeric Peptides Devoid Nausea
Department of Defense, Seattle Children's Research Institute
6/1/20 → 5/31/21
Project: Research project
-
Proposal to Investigate Magnesium Chelates of Interest of Balchem Corporation
Department of Commerce, TAA for Firms
9/9/19 → 9/8/20
Project: Research project
-
Proposal to Investigate Magnesium Chelates of Interest of Balchem Corporation
9/9/19 → 9/8/20
Project: Research project
-
Complexes of Magnesium Maltol (3-Hydroxy-2-methyl-4H-pyran-4-one) for Oral Supplementation
Doyle, R. P. & Case, D., Mar 24 2022, Sep 17 2021, Priority date Sep 17 2020, Priority No. 63/079,743Research output: Patent
-
Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Borner, T., Tinsley, I. C., Doyle, R. P., Hayes, M. R. & De Jonghe, B. C., Feb 2022, In: British Journal of Pharmacology. 179, 4, p. 542-556 15 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations -
Monomeric Peptide Multi-Agonist Targeting the GLP1 Receptor and NPY Receptors
Doyle, R. P. & Milliken, B. T., Jun 30 2022, Apr 1 2020, Priority date Apr 1 2019, Priority No. 62/827,229Research output: Patent
-
Peptide Drug Improvement Using Vitamin B12 and Haptocorrin Binding Substrate Conjugates
Doyle, R. P., Jun 16 2022, Dec 22 2021, Priority date Aug 9 2016, Priority No. 62/372,605Research output: Patent
-
Peptide Ligands of the GDNF Family Receptor A-Like (GFRAL) Receptor
Doyle, R. P., Hayes, M. R., Borner, T., De Jonghe, B. C. & Tinsley, I., Apr 28 2022, Aug 2 2021, Priority date Feb 5 2019, Priority No. 62/801,391Research output: Patent
Press and Media
-
AANDS | MAXWELL ALUMNI MAKING A DIFFERENCE AT MODERNA
Robert Patrick Doyle & Olga Makhylnets
12/21/22
1 item of Media coverage
Press/Media: Expert Comment
-
US Patent Issued to SYRACUSE UNIVERSITY on Dec. 28 for "Peptide drug improvement using vitamin B12 and haptocorrin binding substrate conjugates" (New York Inventor)
12/29/21
1 item of Media coverage
Press/Media: Expert Comment
-
Australia Patent: Syracuse University, Xeragenx File Application for 'Pharmaceutical formulations and methods for delivering a therapeutic, diagnostic, or imaging agent to CD206'
12/17/21
1 item of Media coverage
Press/Media: Expert Comment
-
This week: Ovarian cancer, diabetes drug development, graft-versus-host disease
12/12/21
1 item of Media coverage
Press/Media: Expert Comment
-
'Hexies' exhibit highlights Underground Railroad stories
9/11/21
1 item of Media coverage
Press/Media: Expert Comment